Ohr Pharmaceutical (OHRP) Tops Q1 EPS by 2c

Ohr Pharmaceutical (NASDAQ: OHRP) reported Q1 EPS of ($0.18), $0.02 better than the analyst estimate of ($0.20).

For earnings history and earnings-related data on Ohr Pharmaceutical (OHRP) click here.

You May Also Be Interested In

• Micron Technology (MU) Tops Q4 EPS by $2.26, Offers Guidance
• Wedbush Reiterates Outperform Rating on Micron Technology (MU)
• Morgan Stanley Starts KB Home (KBH) at Underweight